“The finalisation of this acquisition marks a key milestone on our path of development. We are entering new markets, integrating valuable specialised skills and qualifying our offering in terms of both solutions (LIS and RIS/PACS) and domain knowledge. Our presence in international markets is enhanced, the synergies with our blood management systems are even more significant and the opportunities for innovative integration have multiplied.” We believe we are on the right track to become a key international player in the field of diagnostic solutions”.
Fausto Manzana, Gpi’s Chairman and CEO.
